Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.

The company's newer product, an RSV ( respiratory syncytial virus) vaccine, has also underperformed, contributing "minimal ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

Shares of Moderna plunged 20% Monday after the vaccine maker slashed its forecast of full-year 2025 revenue, as sales of its ...

The Department of Health Services has awarded $590 million to Moderna to speed up the development of flu vaccines, including ...

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market ...

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...